A deadly fungal infection at the shelter of drugs is "sweeping the globe", warn experts

Experts warned that a fungal infection KILLER, immune to drugs, would sweep the world.

The newly discovered germ called Candida auris can stay on skin and objects such as furniture and equipment in hospitals for a long time.

This means that it can spread indirectly between patients and make more vulnerable those with weak immune systems, including the sick, the elderly and babies.

Most disturbing is that C.auris can be resistant to the three major classes of antifungal drugs, leaving little room for treatment for physicians.

Over the past five years, he has hit medical centers around the world, including a neonatal unit in Venzeuala and a hospital in Spain.

He reached the UK in 2015, the intensive care unit of Royal Brompton Hospital London having been forced to close for 11 days as a result of an outbreak.

"Shut up"

Dr. Johanna Rhodes, a specialist in infectious diseases at Imperial College London, said she had received a panicked appeal from the hospital, saying she could not get rid of the mushroom.

She told the New York Times that she had been told, "We have no idea where this product comes from, we've never heard of it." It's spreading like wildfire. powder."

Under his direction, workers sprayed a special chemical around the room used for a patient with C. auris and left for a week.

We have no idea where it comes from. We have never heard of it. It's just spread like wildfire

Dr. Johanna Rhodesnarrated by the Royal Brompton Hospital

They put a plate with gel at the bottom in the middle of the room and the only body that pushed back was C.auris.

But the newspaper reports that its spread was initially kept silent.

The pulmonology and pulmonary hospital alerted the British government and informed the infected patients, but made no public announcement.

Oliver Wilkinson, spokesman for Royal Brompton, said: "It was not necessary to issue a press release during the outbreak."

The latest figures released by Public Health England show that more than 200 patients from 20 NHS trusts in Britain have been infected with C.auris.

Dr. Colin Brown, Medical Microbiology Consultant for Public Health England's National Infection Service, said, "Candida auris is an unusual fungus in the UK and our enhanced surveillance shows a low risk for patients in institutions. health.

"Most of the cases detected did not show any symptoms or developed an infection as a result of the fungus.

"PHE is working closely with the NHS to provide expert support and advice on infection control measures to limit the spread of Candida auris.

"NHS hospitals that have experienced outbreaks of Candida auris have not found it as a cause of death in any patient."

In the United States, 587 cases were reported, mainly in New York, New Jersey and Illinois, which led the Center for Disease Control and Prevention (CDC) to add C.auris to its list of "urgent threats".

A study published last year in the journal Emerging Infectious Diseases revealed that 45% of patients had died within 90 days of the diagnosis of the infection.

Nearly all samples from 51 patients in New York City facilities were resistant to fluconazole, a commonly used antifungal drug.

---

We pay for your stories! Do you have a story for the Sun Online press team? Send us an email at [email protected] or call 0207 782 4368. You can get us WhatsApp at 07810 791 502. We also pay for videos. Click here to download yours.